Henriksen Trine F, Fryzek Jon P, Hölmich Lisbet R, McLaughlin Joseph K, Kjøller Kim, Høyer Annette Pernille, Olsen Jørgen H, Friis Søren
The Danish Registry for Plastic Surgery of the Breast, DK-2100 Copenhagen, Denmark.
Ann Plast Surg. 2005 Apr;54(4):343-51. doi: 10.1097/01.sap.0000151459.07978.fa.
Epidemiologic data on local complications after breast augmentation are scarce. In particular, few prospectively collected data are available on modern breast implants on this issue. Using data from the Danish Registry for Plastic Surgery of the Breast, the authors examined determinants of surgery-requiring complications and capsular contracture grades III to IV among 2277 women who underwent cosmetic breast implantation from June 1999 through April 2003. During an average follow-up period of 1.6 years after implantation, 4.3% of these women (3% of implants) required secondary surgery as a result of short-term complications. The most frequent clinical indications for surgery were displacement of the implant (38%), capsular contracture grades III to IV (16%), ptosis (13%), and hematoma (11%). Overall, the authors found that inframammary incision and subglandular placement were associated with decreased risks of developing complications requiring surgical intervention, whereas implants larger than 350 mL increased the risk of such complications (relative risk [RR], 2.3; 95% confidence interval [CI], 1.3-4.0). Thirty-nine Baker III to IV capsular contractures were identified, of which 22 were treated surgically within the study period. Submuscular placement of the implant decreased the risk of capsular contracture grades III to IV (RR, 0.3; 95% CI, 0.2-0.8), whereas surgical routes other than inframammary and drainage of implant cavity were associated with increased risk of capsular contracture. Current surgical practices and modern implants used for breast augmentation produce fewer short-term complications than procedures and devices of the past. This prospective study indicates that surgical procedures are more important predictors for local (short-term) complications than implant or patient characteristics.
关于隆胸术后局部并发症的流行病学数据稀缺。尤其是,关于现代乳房植入物在这一问题上前瞻性收集的数据很少。作者利用丹麦乳房整形手术登记处的数据,对1999年6月至2003年4月期间接受美容性乳房植入手术的2277名女性进行了研究,调查了需要手术治疗的并发症以及III至IV级包膜挛缩的决定因素。在植入后的平均1.6年随访期内,这些女性中有4.3%(植入物的3%)因短期并发症需要二次手术。最常见的手术临床指征是植入物移位(38%)、III至IV级包膜挛缩(16%)、乳房下垂(13%)和血肿(11%)。总体而言,作者发现乳房下皱襞切口和乳腺下放置与需要手术干预的并发症发生风险降低有关,而大于350 mL的植入物会增加此类并发症的风险(相对风险[RR],2.3;95%置信区间[CI],1.3 - 4.0)。共识别出39例Baker III至IV级包膜挛缩,其中22例在研究期间接受了手术治疗。植入物置于胸大肌下可降低III至IV级包膜挛缩的风险(RR,0.3;95% CI,0.2 - 0.8),而除乳房下皱襞外的手术路径和植入物腔引流与包膜挛缩风险增加有关。与过去的手术方法和器械相比,目前用于隆胸的手术方法和现代植入物产生的短期并发症更少。这项前瞻性研究表明,手术方法比植入物或患者特征更能预测局部(短期)并发症。